Here’s a sampling of recent fact checks related to some of the health care claims made during President Donald Trump’s Feb. 4 State of the Union speech.
Category: drug costs
Warren Is Right. Presidents Have The Power To Bypass Congress On Drug Pricing.
But like all of health care, it’s complicated.
A Guide To Following The Health Debate In The 2020 Elections
As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.
Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
Warren and Klobuchar Say They Can Lower Drug Prices Without Congress’ Help
Democratic presidential candidates also returned to now-familiar themes in debating the differences between “Medicare for All” and more incremental reforms.
Sanders Targets Health Industry’ Profits. Are His Figures Right?
Calculations are complicated, but correct.
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
‘Medication insecurity’ is a thing.
KHN’s ‘What The Health?’: ACA Still Under A Cloud After Court Ruling
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
